Y68-25102-90340
3 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 194 / PA
- Registered
- 2021-05-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-17
Dose 1 — Pfizer-BioNTech
-
2021-05-02
Registered in v-safe
- 2021-05-02
-
2021-05-08
Dose 2 — Pfizer-BioNTech
- 2021-05-08
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-17
- 2021-05-24
- 2021-06-07
- 2021-06-12
- 2021-06-21
- 2021-08-07
-
2021-11-08
Survey response — 6 months, dose 2MedDRA: Cough, Diarrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Diarrhea, CoughMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-07-15
Survey response — 6 months, dose 3MedDRA: Stillbirth — Feeling: GoodFree text: stillbirth at 22 weeks and 5 daysMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-17 | Pfizer-BioNTech | |
| 2 | 2021-05-08 | Pfizer-BioNTech | |
| 3 | 2022-01-14 | Pfizer-BioNTech | Flu |
Free text
Release 10 — 6 months, dose 2
Symptoms: Diarrhea, Cough
Release 12 — 6 months, dose 3
Symptoms: stillbirth at 22 weeks and 5 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Stillbirth | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release